ArticleCureus2021
Modular Dual Mobility Constructs Used for Recurrent Hip Instability.
Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review on revision total hip arthroplasty employing the direct anterior approach.Archives of orthopaedic and trauma surgery · 2024Pooled it
- Does the presence of a lipped highly crosslinked polyethylene liner affect the survival of total hip arthroplasty implants? : a registry-based retrospective cohort study.Bone & joint open · 2026Article
- Article
- What is the rate of successful closed reduction of dislocated dual mobility cups following complex revision hip arthroplasty?Archives of orthopaedic and trauma surgery · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Recurrent hip dislocation despite prior attempts at surgical stabilization is a dreadful and technically challenging complication. A modular dual mobility (MDM) articulation has shown promise in addressing this problem, which might seem intractable. Our purpose was to examine the outcomes of revision total hip arthroplasty (THA) with an MDM placed through a direct anterior (DA) approach when all other conservative and surgical treatments have failed. Methods Fifteen patients revised with an MDM for recurrent instability (RI) between 2012 and 2018 by a single surgeon at a single institution were reviewed retrospectively, with a minimum of two years' follow-up. All patients underwent full acetabular revision with an MDM articulation through a DA approach with intraoperative fluoroscopy. No stems were revised. Dislocations, complications, and clinical outcomes are reported. Results All patients had recurrent posterior instability with a mean number of 4 ± 2 (range: 2 to 8) dislocations prior to MDM revision THA (MDM rTHA). Eight patients had already failed surgical intervention for instability, and seven had failed repeated closed reductions and conservative care. After MDM rTHA, there were no dislocations at a mean follow-up of 4 ± 1 years (range: 2 to 8). Similarly, there were no further revisions or reoperations. Postoperatively, the mean cup inclination improved to 45 ± 2 degrees (range: 41 to 48), and the mean anteversion improved to 20 ± 2 degrees (range: 17 to 23). All cups were well-positioned utilizing fluoroscopic guidance. The mean effective head size increased from 32 mm to 44 mm. The mean hip disability and osteoarthritis disability score (HOOS, Jr) was 73 ± 25% (range: 40 to 100). Conclusion Refractory hip instability in THA may be effectively managed with an MDM articulation, even when prior attempts at surgical stabilization have failed. Intraoperative imaging and a direct anterior approach may aid the challenges of implant positioning and achieving hip stability in a revision setting.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.